- Home
- ANVS vs CTW Comparison
ANVS vs CTW Comparison
Compare ANVS & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | CTW |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 93.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANVS | CTW |
|---|---|---|
| Price | $2.69 | $1.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 354.2K | 48.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $1.10 |
| 52 Week High | $5.50 | $3.14 |
Technical Indicators
Market Signals| Indicator | ANVS | CTW |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 48.45 |
| Support Level | $2.27 | $1.10 |
| Resistance Level | $2.97 | $1.77 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 55.50 | 29.14 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About CTW CTW Cayman Class A Ordinary Shares
CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.